Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spring Kong

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Hybrid Imaging|May 22, 2018
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validationBrittany Z Dashevsky, Chenpeng Zhang, Li Yan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2015
A MLC-based inversely optimized 3D spatially fractionated grid radiotherapy techniqueJian-Yue Jin, Bo Zhao, Joseph M Kaminski, et al.
Frontiers in Immunology|July 8, 2022
Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning ApproachHao Yu, Fang Chen, Ka-On Lam, et al.
Journal of Radiation Oncology|September 15, 2015
Radiation dose-fractionation effects in spinal cord: comparison of animal and human dataJian-Yue Jin, Yimei Huang, Stephen L Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancerXu-Wei Cai, Kerby Shedden, Xiaoping Ao, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planningIndrin J Chetty, Mihaela Rosu, Marc L Kessler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2025
Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraintsBen Man Fei Cheung, Kwok Keung Yuen, Mai Yee Luk, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2014
Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysisXiangpeng Zheng, Matthew Schipper, Kelley Kidwell, et al.
Translational Lung Cancer Research|January 25, 2021
Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validationYishan Yu, Linlin Wang, Shufen Cao, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation StudyShulian Wang, Jeff Campbell, Matthew H Stenmark, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Hybrid Imaging|May 22, 2018
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validationBrittany Z Dashevsky, Chenpeng Zhang, Li Yan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2015
A MLC-based inversely optimized 3D spatially fractionated grid radiotherapy techniqueJian-Yue Jin, Bo Zhao, Joseph M Kaminski, et al.
Frontiers in Immunology|July 8, 2022
Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning ApproachHao Yu, Fang Chen, Ka-On Lam, et al.
Journal of Radiation Oncology|September 15, 2015
Radiation dose-fractionation effects in spinal cord: comparison of animal and human dataJian-Yue Jin, Yimei Huang, Stephen L Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancerXu-Wei Cai, Kerby Shedden, Xiaoping Ao, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planningIndrin J Chetty, Mihaela Rosu, Marc L Kessler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2025
Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraintsBen Man Fei Cheung, Kwok Keung Yuen, Mai Yee Luk, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2014
Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysisXiangpeng Zheng, Matthew Schipper, Kelley Kidwell, et al.
Translational Lung Cancer Research|January 25, 2021
Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validationYishan Yu, Linlin Wang, Shufen Cao, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation StudyShulian Wang, Jeff Campbell, Matthew H Stenmark, et al.
Pageof 16